Northland Securities analyst Michael Latimore downgraded C3.ai (AI) stock to a “Hold” rating from “Buy” after the company’s preliminary Q1FY26 results missed its own guidance. Latimore also slashed ...

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), headquartered in Massachusetts, is a global biopharmaceutical enterprise ...

Tom Siebel, c3.ai CEO, joins 'Closing Bell Overtime' to talk quarterly results, recent stock performance, restructuring sales ...

BigBear.ai (BBAI) shares plummeted more than 20% during market action on Tuesday, following second quarter results that ...

C3.ai reported preliminary Q1 results after the bell on Friday, triggering a 30% crash intra-day on Monday. Click here to ...

C3.ai fell for a fourth straight day on Monday, slashing 25.58 percent to close at $16.47 apiece after its chief executive called the preliminary results of its first quarter of fiscal year 2026 ...